These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37741783)

  • 41. The prostatic urethral lift for the treatment of lower urinary tract symptoms associated with prostate enlargement due to benign prostatic hyperplasia: the L.I.F.T. Study.
    Roehrborn CG; Gange SN; Shore ND; Giddens JL; Bolton DM; Cowan BE; Brown BT; McVary KT; Te AE; Gholami SS; Rashid P; Moseley WG; Chin PT; Dowling WT; Freedman SJ; Incze PF; Coffield KS; Borges FD; Rukstalis DB
    J Urol; 2013 Dec; 190(6):2161-7. PubMed ID: 23764081
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New Endoscopic In-office Surgical Therapies for Benign Prostatic Hyperplasia: A Systematic Review.
    Tzeng M; Basourakos SP; Lewicki PJ; Hu JC; Lee RK
    Eur Urol Focus; 2022 Mar; 8(2):522-531. PubMed ID: 33663982
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Systematic Review and Meta-analysis of Functional Outcomes and Complications Following Transurethral Procedures for Lower Urinary Tract Symptoms Resulting from Benign Prostatic Obstruction: An Update.
    Cornu JN; Ahyai S; Bachmann A; de la Rosette J; Gilling P; Gratzke C; McVary K; Novara G; Woo H; Madersbacher S
    Eur Urol; 2015 Jun; 67(6):1066-1096. PubMed ID: 24972732
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial.
    Abt D; Hechelhammer L; Müllhaupt G; Markart S; Güsewell S; Kessler TM; Schmid HP; Engeler DS; Mordasini L
    BMJ; 2018 Jun; 361():k2338. PubMed ID: 29921613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Physical activity for lower urinary tract symptoms secondary to benign prostatic obstruction.
    Silva V; Grande AJ; Peccin MS
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD012044. PubMed ID: 30953341
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Phosphodiesterase inhibitors for lower urinary tract symptoms consistent with benign prostatic hyperplasia.
    Pattanaik S; Mavuduru RS; Panda A; Mathew JL; Agarwal MM; Hwang EC; Lyon JA; Singh SK; Mandal AK
    BJU Int; 2019 Jul; 124(1):27-34. PubMed ID: 30681264
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Medical Treatment Incidence and Persistence After Surgical Relief of Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Obstruction: A Critical Analysis of the Literature.
    Rieken M; de Nunzio C; Cornu JN; Ramasamy R; Misrai V; Malde S; Oelke M; Gacci M; Madersbacher S
    Eur Urol Focus; 2024 May; 10(3):421-431. PubMed ID: 37758614
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Do patients have to choose between ejaculation and miction? A systematic review about ejaculation preservation technics for benign prostatic obstruction surgical treatment.
    Lebdai S; Chevrot A; Doizi S; Pradere B; Delongchamps NB; Benchikh A; Cornu JN; Della Negra E; Fourmarier M; Misraï V; Theveniaud PE; Descazeaud A; Robert G;
    World J Urol; 2019 Feb; 37(2):299-308. PubMed ID: 29967947
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Randomized Comparison of Prostatic Artery Embolization versus Transurethral Resection of the Prostate for Treatment of Benign Prostatic Hyperplasia.
    Insausti I; Sáez de Ocáriz A; Galbete A; Capdevila F; Solchaga S; Giral P; Bilhim T; Isaacson A; Urtasun F; Napal S
    J Vasc Interv Radiol; 2020 Jun; 31(6):882-890. PubMed ID: 32249193
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Temporary implantable nitinol device for benign prostatic hyperplasia-related lower urinary tract symptoms: over 48-month results.
    Amparore D; De Cillis S; Schulman C; Kadner G; Fiori C; Porpiglia F
    Minerva Urol Nephrol; 2023 Dec; 75(6):743-751. PubMed ID: 37350585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An updated meta-analysis of prostatic arterial embolization versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia.
    Xu XJ; Li J; Huang XZ; Liu Q
    World J Urol; 2020 Oct; 38(10):2455-2468. PubMed ID: 31813027
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Randomised Clinical Trial of Prostatic Artery Embolisation Versus a Sham Procedure for Benign Prostatic Hyperplasia.
    Pisco JM; Bilhim T; Costa NV; Torres D; Pisco J; Pinheiro LC; Oliveira AG
    Eur Urol; 2020 Mar; 77(3):354-362. PubMed ID: 31831295
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Systematic review and network meta-analysis of re-intervention rates of new surgical interventions for benign prostatic hyperplasia.
    Shin BNH; Qu L; Rhee H; Chung E
    BJU Int; 2024 Aug; 134(2):155-165. PubMed ID: 38600763
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study.
    Gratzke C; Barber N; Speakman MJ; Berges R; Wetterauer U; Greene D; Sievert KD; Chapple CR; Patterson JM; Fahrenkrug L; Schoenthaler M; Sonksen J
    BJU Int; 2017 May; 119(5):767-775. PubMed ID: 27862831
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial.
    Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
    Can J Urol; 2020 Feb; 27(1):10072-10079. PubMed ID: 32065861
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact on Sexual Function of Endoscopic Enucleation
    Liu Y; Cheng Y; Zhuo L; Liu K; Xiao C; Zhao R; Lu J; Ma L
    J Endourol; 2020 Oct; 34(10):1064-1074. PubMed ID: 32242462
    [No Abstract]   [Full Text] [Related]  

  • 57. A prospective randomized study comparing bipolar plasmakinetic transurethral resection of the prostate and monopolar transurethral resection of the prostate for the treatment of Benign Prostatic Hyperplasia: efficacy, sexual function, Quality of Life, and complications.
    Otaola-Arca H; Álvarez-Ardura M; Molina-Escudero R; Fernández MI; Páez-Borda Á
    Int Braz J Urol; 2021; 47(1):131-144. PubMed ID: 33047918
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Efficacy and safety of prostate artery embolization for benign prostatic hyperplasia: an observational study and propensity-matched comparison with transurethral resection of the prostate (the UK-ROPE study).
    Ray AF; Powell J; Speakman MJ; Longford NT; DasGupta R; Bryant T; Modi S; Dyer J; Harris M; Carolan-Rees G; Hacking N
    BJU Int; 2018 Aug; 122(2):270-282. PubMed ID: 29645352
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Two-Year Outcomes After Aquablation Compared to TURP: Efficacy and Ejaculatory Improvements Sustained.
    Gilling P; Barber N; Bidair M; Anderson P; Sutton M; Aho T; Kramolowsky E; Thomas A; Cowan B; Kaufman RP; Trainer A; Arther A; Badlani G; Plante M; Desai M; Doumanian L; Te AE; DeGuenther M; Roehrborn C
    Adv Ther; 2019 Jun; 36(6):1326-1336. PubMed ID: 31028614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Transurethral Resection of the Prostate (TURP) Versus Original and PErFecTED Prostate Artery Embolization (PAE) Due to Benign Prostatic Hyperplasia (BPH): Preliminary Results of a Single Center, Prospective, Urodynamic-Controlled Analysis.
    Carnevale FC; Iscaife A; Yoshinaga EM; Moreira AM; Antunes AA; Srougi M
    Cardiovasc Intervent Radiol; 2016 Jan; 39(1):44-52. PubMed ID: 26506952
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.